Poseida Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
For our next presentation. Hi, everyone. Welcome. I'm Jennifer Kim, one of the research analysts at Cantor Fitzgerald, and I'm looking forward to hosting Mark Gergen, the CEO and Chairman of Poseida Therapeutics.
Mark, thanks for joining us.
Well, thanks for having us, Jennifer. Happy to be here.
Okay. Happy to have you here. So, maybe as an intro for those less familiar with the story, do you want to give a brief background of yourself and the company?
Sure. I won't bore them too much. I'm the, obviously, the Chairman and CEO. Started as the CFO about five years ago. I've been in healthcare 30 years and biotech 25 years. Probably most notable, I was at Amylin Pharmaceuticals up to the sale to BMS in 2012. And then I helped to start a company now called Mirati Therapeutics.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |